
Eckert & Ziegler Strahlen und Medizintechnik AG
XETRA:EUZ

Intrinsic Value
The intrinsic value of one
EUZ
stock under the Base Case scenario is
57.73
EUR.
Compared to the current market price of 48.4 EUR,
Eckert & Ziegler Strahlen und Medizintechnik AG
is
Undervalued by 16%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Eckert & Ziegler Strahlen und Medizintechnik AG
Fundamental Analysis



Revenue & Expenses Breakdown
Eckert & Ziegler Strahlen und Medizintechnik AG
Balance Sheet Decomposition
Eckert & Ziegler Strahlen und Medizintechnik AG
Current Assets | 277.2m |
Cash & Short-Term Investments | 97.6m |
Receivables | 63.2m |
Other Current Assets | 116.5m |
Non-Current Assets | 203.7m |
Long-Term Investments | 20.9m |
PP&E | 115.9m |
Intangibles | 52.5m |
Other Non-Current Assets | 14.4m |
Free Cash Flow Analysis
Eckert & Ziegler Strahlen und Medizintechnik AG
EUR | |
Free Cash Flow | EUR |
Earnings Waterfall
Eckert & Ziegler Strahlen und Medizintechnik AG
Revenue
|
277.7m
EUR
|
Cost of Revenue
|
-144.4m
EUR
|
Gross Profit
|
133.3m
EUR
|
Operating Expenses
|
-73.1m
EUR
|
Operating Income
|
60.3m
EUR
|
Other Expenses
|
-30.9m
EUR
|
Net Income
|
29.4m
EUR
|
EUZ Profitability Score
Profitability Due Diligence
Eckert & Ziegler Strahlen und Medizintechnik AG's profitability score is 58/100. The higher the profitability score, the more profitable the company is.

Score
Eckert & Ziegler Strahlen und Medizintechnik AG's profitability score is 58/100. The higher the profitability score, the more profitable the company is.
EUZ Solvency Score
Solvency Due Diligence
Eckert & Ziegler Strahlen und Medizintechnik AG's solvency score is 83/100. The higher the solvency score, the more solvent the company is.

Score
Eckert & Ziegler Strahlen und Medizintechnik AG's solvency score is 83/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
EUZ Price Targets Summary
Eckert & Ziegler Strahlen und Medizintechnik AG
According to Wall Street analysts, the average 1-year price target for
EUZ
is 64.41 EUR
with a low forecast of 60.9 EUR and a high forecast of 69.3 EUR.
Dividends
Current shareholder yield for EUZ is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
EUZ
stock under the Base Case scenario is
57.73
EUR.
Compared to the current market price of 48.4 EUR,
Eckert & Ziegler Strahlen und Medizintechnik AG
is
Undervalued by 16%.